Page last updated: 2024-09-03

n-acetyllactosamine and Cardiac Failure

n-acetyllactosamine has been researched along with Cardiac Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bank, RA; Bos, EM; de Boer, RA; Goldstein, IJ; Koerts, JA; Meissner, M; Pitt, B; Ruifrok, WP; Sanjabi, B; Silljé, HH; van der Harst, P; van Gilst, WH; van Goor, H; van Veldhuisen, DJ; Yu, L	1

Other Studies

1 other study(ies) available for n-acetyllactosamine and Cardiac Failure

Article	Year
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circulation. Heart failure, 2013, Volume: 6, Issue:1 Topics: Amino Sugars; Animals; Cardiomyopathies; Collagen Type I; Disease Models, Animal; DNA; Fibrosis; Galectin 3; Gene Expression; Heart Failure; Immunohistochemistry; Male; Mice; Mice, Knockout; Myocardium; Rats; Reverse Transcriptase Polymerase Chain Reaction; Ventricular Remodeling	2013

Article

Year

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.

Circulation. Heart failure, 2013, Volume: 6, Issue:1

Topics: Amino Sugars; Animals; Cardiomyopathies; Collagen Type I; Disease Models, Animal; DNA; Fibrosis; Galectin 3; Gene Expression; Heart Failure; Immunohistochemistry; Male; Mice; Mice, Knockout; Myocardium; Rats; Reverse Transcriptase Polymerase Chain Reaction; Ventricular Remodeling

2013